Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joaquina Celebre Baranda

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 5, 2023
Equitable Access to Clinical Trials: How Do We Achieve It?Ana Acuña-Villaorduña, Joaquina Celebre Baranda, Jessica Boehmer, et al.
Exploration of Targeted Anti-Tumor Therapy|July 17, 2023
Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapyStijn Hentzen, Kathan Mehta, Raed Moh'd Taiseer Al-Rajabi, et al.
The Oncologist|June 6, 2026
Niraparib in pancreatic cancer with germline or somatic DNA damage repair (DDR) gene alterations (BRCA and beyond): A phase II study (NIRA-PANC)Anup Kasi, Raed Moh'd Taiseer Al-Rajabi, Joaquina Celebre Baranda, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 5, 2023
Equitable Access to Clinical Trials: How Do We Achieve It?Ana Acuña-Villaorduña, Joaquina Celebre Baranda, Jessica Boehmer, et al.
Exploration of Targeted Anti-Tumor Therapy|July 17, 2023
Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapyStijn Hentzen, Kathan Mehta, Raed Moh'd Taiseer Al-Rajabi, et al.
The Oncologist|June 6, 2026
Niraparib in pancreatic cancer with germline or somatic DNA damage repair (DDR) gene alterations (BRCA and beyond): A phase II study (NIRA-PANC)Anup Kasi, Raed Moh'd Taiseer Al-Rajabi, Joaquina Celebre Baranda, et al.
Pageof 1